Cancer Research

Tuesday, May 23, 2017 - 4:03pm

Ten years ago, patients diagnosed with advanced-stage kidney cancer had few options, and none of them were very promising. But in recent years, we have seen a revolution in kidney cancer treatment with ten new targeted drugs winning FDA approval.

Monday, May 15, 2017 - 2:47pm

Is there a connection between certain types of cancer and diabetes? There could be, although the relationship is a complex one, according to Rajeev Sharma, MBBS, MD, FACE.

“Diabetes and cancer have many common risk factors and a potential biological link might exist as both diseases are diagnosed in the same person more frequently compared to a person without diabetes,” explains Dr. Sharma. 

Friday, April 14, 2017 - 10:24am

In December, the Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) announced a major collaboration focused on an emerging area of cancer research: neoantigens. These small proteins on the surface of cancer cells arise from mutations often unique to a tumor, making personalized immunotherapies like cancer vaccines a possibility.

Wednesday, April 12, 2017 - 4:24pm

When it comes to medical treatments, we’re not all alike. Women and men sometimes need different dosages of the same drug. One drug for heart failure works very well in black patients but not in white patients.

Thursday, February 16, 2017 - 2:31pm

Take it from George Grace: if you’ve smoked your entire life, you listen closely to news about innovative cancer treatments. Grace listened, even before a spot on his lung led to a diagnosis of early-stage non-small cell lung cancer.

Saturday, February 18, 2017 - 10:26am

The National Cancer Institute (NCI) established an initiative recently that I expect to benefit patients at Roswell Park Cancer Institute (RPCI) and around the country for years to come.

In January 2017, the agency, a member institution of the National Institutes of Health, launched the NCI Formulary to expand access to both approved drugs and investigational agents — that is, drugs still in development — that have shown promise as possible cancer therapies.

Thursday, December 29, 2016 - 12:31pm

In 2006, Shinya Yamanaka, a Japanese stem cell researcher, made a groundbreaking discovery that would win him the Nobel Prize. Yamanaka discovered a new way to turn adult, dividing cells into pluripotent stem cells.

Thursday, September 8, 2016 - 3:19pm

The report released yesterday by the Cancer Moonshot Blue Ribbon Panel, a group convened by Vice President Biden last winter, highlighted some big ideas and high-impact opportunities in oncology.

Monday, August 15, 2016 - 4:53pm

In 1951, Edwin A. Mirand, PhD, DSc became a permanent employee of Roswell Park Cancer Institute. What would have been impossible to know at the time was just how permanent a fixture he would truly become.

Friday, June 17, 2016 - 2:03pm
Danielle Twum is making it her mission to educate the public about the cutting-edge research taking place at Roswell Park, and how these breakthroughs change the way we treat cancer. The third-year pre-doctoral candidate, studying immunology in Dr. Scott Abrams’ lab, spearheaded her efforts last fall with a compelling presentation at TEDxBuffalo, an independent, local version of TED Talks.